tbuckley/cabot-search huggingface dataset:
Epigenetic Fine Mapping and Functional Dissection of Inherited Non-Coding Variation Impacting the Pharmacogenomics of Acute Lymphoblastic Leukemia Treatment
Authors: Kashi Raj Bhattarai, Kelly R. Barnett, Robert J. Mobley, Daniel C. Ferguson, Jonathan D. Diedrich, Brennan P. Bergeron, Wenjian Yang, Kristine R. Crews, Wendy Stock, Elisabeth Paietta, Steven M. Kornblau, Hiroto Inaba, Sima Jeha, Ching-Hon Pui, Cheng Cheng, Mary V. Relling, William E. Evans, Jun J.J. Yang, Daniel Savic
Journal: Blood (2022)
Ciltacabtagene Autoleucel (Cilta-cel), a BCMA-Directed CAR-T Cell Therapy, in Patients with Multiple Myeloma (MM) and Early Relapse after Initial Therapy: CARTITUDE-2 Cohort B 18-Month Follow-up
Authors: Niels WCJ Van De Donk, Mounzer Agha, Adam D Cohen, Yael C Cohen, Sébastien Anguille, Tessa Kerre, Wilfried W.H. Roeloffzen, Jordan M Schecter, Kevin C De Braganca, Carolyn C Jackson, Helen Varsos, Pankaj Mistry, Tito Roccia, Xiaoying Xu, Katherine Li, Enrique Zudaire, Christina Corsale, Muhammad Akram, Dong Geng, Lida Pacaud, Pieter Sonneveld, Sonja Zweegman
Journal: Blood (2022)
Poor Survival Outcomes of Checkpoint Inhibitors for B-Cell Lymphomas Relapsing after or Refractory to CAR T-Cell Therapy: A Real-World Cohort from 15 U.S. Academic Institutions
Authors: Ajay Major, Jovian Yu, Navika D. Shukla, Rachel Treitman, Manali K. Kamdar, Bradley M. Haverkos, James Godfrey, Melissa A. Babcook, Timothy J. Voorhees, Sophie G Carlson, Daria Gaut, Caspian Oliai, Jason T. Romancik, Allison Winter, Brian T. Hill, Radhika Bansal, Jose C. Villasboas, Imran A. Nizamuddin, Reem Karmali, Lindsey A. Fitzgerald, Deborah M. Stephens, Priyanka A. Pophali, Asaad Trabolsi, Jonathan H. Schatz, Marie Hu, Veronika Bachanova, Michael J Slade, Nathan Singh, Nausheen Ahmed, Joseph P. McGuirk, Michael R. Bishop, Peter A. Riedell, Justin Kline
Journal: Blood (2022)
Brentuximab Vedotin, Nivolumab, Doxorubicin, and Dacarbazine (AN+AD) for Early Stage Classic Hodgkin Lymphoma: Interim Efficacy and Safety Results from the Single-Arm Phase 2 Study (SGN35-027 Part C)
Authors: Hun Ju Lee, Jeremy S. Abramson, Nancy L. Bartlett, John M. Burke, Ryan C. Lynch, Domingo Domenech Eva, Brian T. Hess, Steven R. Schuster, Yuliya Linhares, Rod Ramchandren, Mitul Gandhi, Rex Mowat, Harsh Shah, Giuseppe Rossi, Uwe H Hahn, Henry Miles Prince, Linda Ho, Wenchuan Guo, Christopher A. Yasenchak, David J. Straus
Journal: Blood (2022)
Enhancing α-CD19 CAR T Antitumor Efficacy Using the BH3 Mimetic, Venetoclax
Authors: Taylor Mandeville, Cory Mavis, Juan Gu, Noah Lemoine, Kevin Bowman, Scott Olejniczak, Prasenjit Dey, Gyorgy Paragh, Francisco Hernandez-Ilizaliturri
Journal: Blood (2022)
Ruxolitinib in Acute and Chronic Graft-Versus-Host Disease: Real Life Experience in a Multi-Centre Study
Authors: Virginia Escamilla Gomez, Valentín García Gutiérrez, Beatriz Astibia Mahillo, Patricia Alcalde, Lucía López Corral, Marina Acera Gómez, Melissa Torres, Asunción Borrego Borrego, Leslie González Pinedo, Maite Zudaire, Marta González Vicent, Ana Benzaquén, Isabel Izquierdo Garcia, Pedro Asensi, Juan Montoro Gómez, Guillermo Orti Pascual, David Valcárcel, Maria Isabel Benitez Carabante, Cristina Díaz de Heredia Rubio, Eloi Cañamero Giro, Christelle Ferrà, Irene García-Cadenas, Sara Redondo, Luisa Sisinni, Antonio Perez, Alberto Mussetti, Lucía García, María Del Pilar Palomo Moraleda, Pedro Antonio González Sierra, Manuel Jurado Chacón, Jose A. Perez-Simon
Journal: Blood (2022)
Sars-Cov-2-Specific CD4+ and CD8+ T Cell Responses Can Originate from Cross-Reactive CMV-Specific T Cells
Authors: Cilia R. Pothast, Romy C. Dijkland, Melissa Thaler, Renate S. Hagedoorn, Michel G.D. Kester, Anne K. Wouters, Pieter S. Hiemstra, Martijn J. van Hemert, Stephanie Gras, J.H. Frederik Falkenburg, Mirjam H.M. Heemskerk
Journal: Blood (2022)
Outcomes with Post-Transplant Cyclophosphamide for Graft Versus Host Disease Prophylaxis after Allogeneic Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis
Authors: Moazzam Shahzad, Qamar Iqbal, Sara J Zaidi, Amna Y Shah, Reem Sulaiman, Mamoon Ahmed, Ammad Naeem, Sorosh Daud, Iqra Anwar, Sibgha Gull Chaudhary, Peiman Hematti, Sunil H Abhyankar, Joseph P. McGuirk, Muhammad Umair Mushtaq
Journal: Blood (2022)
Real-World Treatment (Tx) Patterns and Clinical Outcomes Among Patients (Pts) with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) Who Received at Least 2 Prior Lines of Therapy Including Bruton Tyrosine Kinase Inhibitor (BTKi) and/or B-Cell Lymphoma 2 Inhibitor (BCL2i)
Authors: Farrukh T. Awan, Gaurav A. Deshpande, Trong Kim Le, Sean Garrison, Simran K. Tiwana, Masoom Priyadarshini
Journal: Blood (2022)
The Impact of Pre-Transplant Extramedullary Disease on the Outcome of Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia in Children- on Behalf of PDWP/EBMT
Authors: Juliana Silva, Jacques-Emmanuel Galimard, Jean-Hugues Dalle, Franco Locatelli, Hawazen S. Alsaedi, Miguel Angel Diaz, Charlotte Jubert, Yves Bertrand, Giuseppina Simone, Peter Bader, Franca Fagioli, Vassiliki Kitra Roussou, Caroline Furness, Robert Wynn, Birgit Burkhardt, Alessandra Biffi, Marc Bierings, Cristina Díaz de Heredia, Arcangelo Prete, Amos Toren, Katharine Patrick, Wolfgang Holter, Arnaud Dalissier, Kanchan Rao, Selim Corbacioglu
Journal: Blood (2022)
Microbial Bile Acid Metabolism Shapes Effector T Cell Responses during Inflammation in Mouse and Human
Authors: Sarah Lindner, Oriana Miltiadous, Ruben J Ramos, Anqi Dai, Anastasia Kousa, Gabriel K Armijo, Romina Ghale, Chi L Nguyen, Jenny Paredes Sanchez, Teng Fei, John W Frame V, Sebastien Monette, Emily Fontana, John Slingerland, Ying Taur, Marina D Burgos da Silva, Kate A Markey, Jonathan U Peled, Melody Smith, Sergio A Giralt, Miguel-Angel Perales, Justin R Cross, Clarissa Campbell, Marcel R M van den Brink
Journal: Blood (2022)
Graft Versus Leukaemia (GvL): Identification &amp; Characterisation of Alloreactive Antigens and Cognate T Cell Responses in Acute Myeloid Leukemia
Authors: Connor Sweeney, Gerda Mickute, Kinam Gupta, Marlen Metzner, Batchimeg Usukhbayar, Maria Chiara Barbanti, Gavinda Sangha, Ronjon Chakraverty, Persephone Borrow, Nicola Ternette, Ane Ogbe, Maria Aggelakopoulou, Paresh Vyas
Journal: Blood (2022)
Clinical Response to Azacytidine (AZA) Is Associated with Increased Contribution from Mutated Blood Progenitors: Insights from Single Cell Genotyping of Matched Stem/Progenitor and Mature Blood Cells from MDS/CMML Patients Pre- and Post-AZA Treatment
Authors: Julie A.I. Thoms, Annatina Schnegg-Kaufmann, Golam Sarower Bhuyan, Henry R. Hampton, Lachlin Vaughan, Kayleigh Rutherford, Purvi M. Kakadia, Hui Mei Lee, Emma Johansson, Tim W. Failes, Greg M. Arndt, Jason Koval, Sarah Davidson, Robert Lindeman, Pauline Warburton, Alba Rodriguez-Meira, Adam J Mead, Ashwin Unnikrishnan, Mark Hertzberg, Mark N. Polizzotto, Elli Papaemmanuil, Stefan K. Bohlander, Omid Faridani, Christopher J. Jolly, Fabio Zanini, John E. Pimanda
Journal: Blood (2022)
Targeting Myeloid Leukemia Using Novel TCR-like Chimeric Antigen Receptor-T Cells Against Cathepsin G
Authors: Jun Yan, Ze Tian, Chunhua Shi, Mao Zhang, Pariya Sukhumalchandra, Guojan Yang, Qing Edward Chang, Junping You, Meng Cui, Qing Shi, Anne Philip, Na Qiao, Anna Sergeeva, Lisa St John, Hong He, Dongxing Zha, Jeffrey J. Molldrem, Gheath Alatrash
Journal: Blood (2022)
Exploring the Impact of Humoral Immunogenicity with Tabelecleucel for the Treatment of EBV+ PTLD Following HCT and SOT
Authors: Tassja J Spindler, Fiona Ruiz, Tiffany Jehng, Hanna Ding, Norma Guzman-Becerra, Shahram Khanzadeh, Xiaoming Li, Laurence Gamelin, Jason A. Dubovsky, Cokey Nguyen
Journal: Blood (2022)
MiRNA29B Induces Fetal Hemoglobin through Targeting DNMT3 and MYB in Vitro and In Vivo in Preclinical Townes Sickle Cell Mice
Authors: Ernestine Amos-Abanyie, Chithra Palani, Alana Smith, Qingqing Gu, Ugochi Ogu, Daniel Johnson, Umapathy N Siddaramappa, Betty S. Pace, Athena Starlard-Davenport
Journal: Blood (2022)
Methylome Analysis of Epstein-Barr Virus with Nanopore Sequencing Reveals Viral State Dynamics
Authors: Christoph Weigel, Esko Kautto, Elshafa H. Ahmed, Yue-Zhong Wu, Charles T. Gregory, Ada C. Cleary, Sarah Y. Schlotter, Eric Brooks, Mark Lustberg, Robert A. Baiocchi, James S. Blachly, Christopher C. Oakes
Journal: Blood (2022)
Clinical Outcomes Following Allogeneic Hematopoietic Cell Transplantation with Omidubicel or Other Donor Sources in Patients with Hematologic Malignancies: Comparison of Clinical Trial Results to Center for International Blood and Marrow Transplant Research Database Controls
Authors: Smitha Sivaraman, Gautam Sajeev, Yan Song, Chunyi Xu, Chujun He, James E. Signorovitch, Heayoung Shin, Rocio Manghani, Xiao-Ying Tang, Mei-Je Zhang, Linda J Burns, Ronit Simantov
Journal: Blood (2022)
Targeting PLZF Enhances Glucocorticoid Sensitivity in Acute Myeloid Leukemia
Authors: Azadeh Hajmirza, Laura Simon, Jalila Chagraoui, Nadine Mayotte, Jean-François Spinella, Tara Macrae, Bernhard Lehnertz, Thierry Bertomeu, Jasmin Coulombe-Huntington, Geneviève Boucher, Sébastien Lemieux, Mike Tyers, Josee Hebert, Guy Sauvageau
Journal: Blood (2022)
A Phase I Trial Assessing the Feasibility of Romidepsin Combined with Brentuximab Vedotin for Patients Requiring Systemic Therapy for Cutaneous T-Cell Lymphoma
Authors: Stefan K. Barta, Tatyana A. Feldman, Jennifer A. DeSimone, Ellen Kim, Karthik Devajaran, Yibin Yang, Henry C. Fung, Tafseer Mahvish, Shazia Nakhoda, Nadia Khan
Journal: Blood (2022)
The Role of Heterozygous Variants in <i>SAMD9/9L</i> and Recessive Bone Marrow Failure-Related Genes in Adults with Severe Aplastic Anemia
Authors: Dalton Hironaka, Xiaoyang Ma, Bhavisha A. Patel, Emma M. Groarke, Jennifer Lotter, Olga Rios, Juan L Coelho-Silva, Colin O. Wu, Jorg Cammenga, Fernanda Gutierrez-Rodrigues, Neal S. Young
Journal: Blood (2022)
Peripheral Neuropathy in Children with High Risk Hodgkin Lymphoma (HL): The Role of Protocol-Stipulated Dose Modification in the Children's Oncology Group (COG) AHOD1331 Study
Authors: Susan K. Parsons, Frank G. Keller, Qinglin Pei, Angie Mae Rodday, Jennifer Belsky, Yue Wu, Angela Punnett, Tara O Henderson, Kara M. Kelly, Sharon M. Castellino
Journal: Blood (2022)
Next-Generation Sequencing of Newly-Diagnosed Primary CNS Lymphoma Reveals Alterations in BTG1, ETV6, and 6p Are Associated with Chemoresistance and Inferior Progression-Free Survival
Authors: Shirley S. Mo, Huimin Geng, Miguel Cerejo, Kwun Wah Wen, David A. Solomon, James L. Rubenstein
Journal: Blood (2022)
Impact of Trial Eligibility Criteria on Outcomes of 1,245 Patients with Follicular Lymphoma Treated in the Real-World Setting: A Danish Population-Based Study
Authors: Tine Bennedsen, Mikkel Simonsen, Peter de Nully Brown, Michael Roost Clausen, Andriette Dessau-Arp, Judit Jørgensen, Thomas S. Larsen, Christian Bjørn Poulsen, Lasse Hjort Jakobsen, Tarec Christoffer Christoffer El-Galaly
Journal: Blood (2022)
Venous Thromboembolism in Children, Adolescents and Young Adults: Findings from the Riete Registry
Authors: Omri Cohen, Assaf Arie Barg, Ulrike Nowak-Göttl, Reina Valle, Lucia Mazzolai, Gregorio Tiberio, Sebastian Schellong, Andris Skride, Mª del Valle Morales, Manuel Monreal, Gili Kenet
Journal: Blood (2022)
Prospective Study of Immune Phenotype and Associated Outcomes in Patients with Leukemia and Acute Respiratory Distress Syndrome
Authors: Lukas Ronner, Heather M. Giannini, Todd A. Miano, Caroline A.G. Ittner, Alexandra P. Turner, Thomas G. Dunn, Roseline S. Agyekum, Anushka Dasgupta, Kirsten West, Tiffanie K. Jones, Michael G.S. Shashaty, John P. Reilly, Nuala J. Meyer
Journal: Blood (2022)
Gimema AML1718 Part 1: Planned Interim Analysis of a Safety Run-in and Phase 2 Open-Label Study of Venetoclax, Fludarabine, Idarubicin and Cytarabine (V-FLAI) in the Induction Therapy of Non Low-Risk Acute Myeloid Leukemia
Authors: Giovanni Marconi, Alfonso Piciocchi, Ernesta Audisio, Giorgio Priolo, Cristina Papayannidis, Maurizio Martelli, Francesca Paoloni, Roberto Massimo Lemoli, Monica Bocchia, Francesco Lanza, Albana Lico, Fabio Ciceri, Matteo G. Della Porta, Marco Frigeni, Luisa Giaccone, Germana Beltrami, Erika Borlenghi, Maria Chiara Di Chio, Carmine Selleri, Enrico Crea, Irene Urbino, Chiara Sartor, Clara Minotti, Fabio Guolo, Edoardo La Sala, Jacopo Nanni, Giorgia Simonetti, Maria Teresa Bochicchio, Giuseppe Saglio, Adriano Venditti, Marco Vignetti, Paola Fazi, Giovanni Martinelli
Journal: Blood (2022)
Diagnostic and Prognostic Utility of Flowcytometric Enumeration of Circulating Stem Cells with h-Micl Expression in BCR-ABL1-Negative Myeloproliferative Neoplasms
Authors: Gurleen Oberoi, Rishi Dhawan, Jasmita Dass, Seema Tyagi, Ganesh Viswanathan, Mukul Agarwal, Pradeep Kumar Kumar, Tulika Seth, Manoranjan Mahapatra, Renu Saxena
Journal: Blood (2022)
Maintenance Therapy with Venetoclax/Azacitidine Can be Safely Given after Venetoclax/FluBu2 RIC Allogeneic Transplantation for the Treatment of High Risk MDS/AML: Results of a Phase 1 Study
Authors: Jacqueline S. Garcia, Haesook T Kim, Jennifer Brock, H. Moses Murdock, Corey S. Cutler, Daniel J. DeAngelo, Christopher J. Gibson, Mahasweta Gooptu, Vincent Ho, John Koreth, Marlise R. Luskin, Sarah Nikiforow, Rizwan Romee, Roman M Shapiro, Richard M. Stone, Martha Wadleigh, Eric S. Winer, Michela Ansuinelli, Eliza Elliot, Geoffrey Fell, Hannah Karp, Jeremy Ryan, Anthony G. Letai, Coleman Lindsley, Robert J Soiffer, Joseph H. Antin, Fiona Loschi, Jerome Ritz
Journal: Blood (2022)
Efficacy and Safety of Gilteritinib Vs. Sorafenib As Post-Transplant Maintenance in Patients with FLT3-ITD Acute Myeloid Leukemia
Authors: Jason Yeh, Rima M. Saliba, Christopher Wang, Zhou Fang, Bradley Figgins, Sairah Ahmed, Musa Yilmaz, Naval Daver, Rohtesh S. Mehta, Gheath Alatrash, David Marin, Uday R Popat, Richard E Champlin, Elizabeth J Shpall, Betul Oran
Journal: Blood (2022)
Clinical and Genetic Characteristics of <i>STAG2</i> Mutations in Myeloid Neoplasms
Authors: Bahga Katamesh, Ahmad Nanaa, Rong He, David S. Viswanatha, Phuong L Nguyen, Patricia Greipp, Kurt Bessonen, Naseema Gangat, Kebede H. Begna, Abhishek A. Mangaonkar, Mrinal M.M. Patnaik, William J. Hogan, Ayalew Tefferi, Mark R. Litzow, Mithun V. Shah, Cecilia Arana Yi, James M. Foran, Talha Badar, Hassan B. Alkhateeb, Aref Al-Kali
Journal: Blood (2022)
Risk of Progression in Chronic Phase-Chronic Myeloid Leukemia (CML) Patients Eligible for Tyrosine Kinase Inhibitor Discontinuation: The Tfr-PRO Study
Authors: Giovanni Zambrotta, Sarit Assouline, Franck E. Nicolini, Elisabetta Abruzzese, Maria Cristina Miggiano, Chiara Elena, Alberto Alvarez-Larran, Ana Triguero, Alessandra Iurlo, Cristina Bucelli, Francesca Lunghi, Isabella Capodanno, Margherita Maffioli, Sara Galimberti, Giovanni Caocci, Fabio Stagno, Susanne Saussele, Carmen Fava, Philipp le Coutre, Massimiliano Bonifacio, Veronica Guglielmana, Federica Colombo, Laura Antolini, Carlo Gambacorti-Passerini
Journal: Blood (2022)
Multiomics Analysis Confirms Effective Target Engagement for RVU120 - a First-in-Class CDK8/19 Kinase Inhibitor in AML and MR-MDS Patients and Reveals the Mechanism of Action
Authors: Tomasz Rzymski, Agnieszka Sroka-Porada, Magdalena Kozakowska, Urszula Głowniak-Kwitek, Karolina Bukowska-Strakova, Marta Obacz, Peter Littlewood, Kamil Kuś, Kristina Goller, Kinga Kęska, Urszula Pakulska, Kamila Kozłowska-Tomczyk, Monika Madej, Milena Mazan, Przemyslaw Juszczynski, Jan M. Zaucha, Agnieszka Zarzycka, Noemi Angelosanto, Hendrik Nogai, Krzysztof Brzózka
Journal: Blood (2022)
Metabolic Adaptation to Tyrosine Kinase Inhibition in Chronic Myelogenous Leukemia Stem Cells
Authors: Shaowei Qiu, Vipul Sheth, Chengcheng Yan, Juan Liu, Balu K. Chacko, Hui Li, David Crossman, Seth D. Fortmann, Sajesan Aryal, Maria B. Grant, Robert S. Welner, Andrew J. Paterson, Adam R. Wende, Victor M Darley-Usmar, Rui Lu, Jason W. Locasale, Ravi Bhatia
Journal: Blood (2022)
Lessons Learned from COVID-19 Pandemic: Outcomes after Sars-Cov-2 Infection in Hematopoietic Cell Transplant and Cell Therapy Recipients
Authors: Muhammad Umair Mushtaq, Joe S Al-Ramahi, Kevin S Li, Moazzam Shahzad, Sibgha Gull Chaudhary, Ramesh Balusu, Nausheen Ahmed, Rajat Bansal, Haitham Abdelhakim, Leyla O. Shune, Anurag K. Singh, Sunil H Abhyankar, Joseph P. McGuirk
Journal: Blood (2022)
CNCT19 CAR T-Cell Therapy in Relapsed or Refractory B-Cell Lymphoma: Long-Term Results of a Pilot Prospective Clinical Study
Authors: Wei Liu, Wenyang Huang, Rui Lv, Huimin Liu, Shuhua Yi, Hong Liu, Lulu Lv, Lugui Qiu, Jianxiang Wang, Dehui Zou
Journal: Blood (2022)
Utility of Procalcitonin and Interleukin-6 As Severe Infection Biomarkers in Adulthematological and Oncological Patients. Real-Life Single Center Prospective Observational Study
Authors: Gaetano Moschetti, Uros Markovic, Daniela Carco, Valeria Iachelli, Paola Guardo, Giulio Antonio Milone, Tecla Pace, Sara Rosaria Stanco, Vincenza Giuffrida, Paola Scire, Gabriella Amato, Federica Galbo, Dario Giuffrida, Dorotea Sciacca, Ivana Puliafito, Gianmarco Motta, Annalisa Bonasera, Giuseppe Milone, Emanuele Martorana, Gaetano Moschetti
Journal: Blood (2022)
Investigating Biomarkers for Primary Immunodeficiency Disorders in Patients with Autoimmune Cytopenia
Authors: David E. Potts, Melis Yilmaz, Boglarka Ujhazi, Cristina Meehan, Maryssa Ellison, Rachel Cruz, Sumai Gordon, Priya Patel, Joseph Dasso, Marisol Betensky, Jennifer Lynne Root Mayer, Anna Meyer, Juan Felipe Rico, Erin Cockrell, Don Eslin, Charles I Hauk, Ambuj Kumar, Daime Nieves, Panida Sriaroon, Jonathan Metts, Irmel Ayala, Mei-Sing Ong, Krisztian Csomos, Emma Westermann-Clark, Jolan E. Walter
Journal: Blood (2022)
Regulation of Fetal Hemoglobin Production in Adult Erythroid Cells By Protein Phosphatase 6C (PPP6C)
Authors: Scott A. Peslak, Eugene Khandros, Peng Huang, Aoi Wakabayashi, Talla Abbas, Osheiza Y. Abdulmalik, Cheryl A. Keller, Ross C. Hardison, Junwei Shi, Gerd A. Blobel
Journal: Blood (2022)
The Potential of E-Health in Patients after Allogeneic Stem Cell Transplantation
Authors: Friederike Schmitz, Charlotte Neuerburg, Martin Schumacher, Udo Holtick, Edgar Jost, Guido Kobbe, Ben-Niklas Bärmann, Marie-Therese Schmitz, Matthias Schmid, Peter Brossart, Martin Holderried, Tobias A.W. Holderried
Journal: Blood (2022)
Prospective Validation of CD34+CD38- Leukemic Stem Cell Frequency in the HOVON-SAKK 132 Trial: Perspectives for Future Improvements
Authors: Lok Lam Ngai, Diana Hanekamp, Fleur Janssen, Jannemieke Carbaat-Ham, Maaike A.M. Hofland, Mona M.H.E Fayed, Angèle Kelder, Laura Oudshoorn-van Marsbergen, Willemijn J. Scholten, Alexander N. Snel, Costa Bachas, Jesse M. Tettero, Dimitri A. Breems, Thomas Fischer, Bjørn Tore Gjertsen, Laimonas Griškevičius, Gunnar Juliusson, Johan A. Maertens, Markus G Manz, Thomas Pabst, Jakob R. Passweg, Kimmo Porkka, Patrycja Gradowska, Bob Lowenberg, David C. de Leeuw, Jeroen J.W.M. Janssen, Gert J. Ossenkoppele, Jacqueline Cloos
Journal: Blood (2022)
Yoga As Possible Non-Medical Intervention to Improve Quality of Life of Patients with Myelodysplastic Syndromes - a Feasibility Report
Authors: Irina Amitai, Ilana Hellmann, Maya Koren-Michowitz, Tsila Zuckerman, Ariel Aviv, Anatoly Nemets, Itai Levi, Yishai Ofran, Moshe Mittelman, Drorit Grizim Merkel
Journal: Blood (2022)
Cellular Plasticity As Mechanisms to Escape from NOTCH1-Inhibition in T-ALL
Authors: Valeriya Dimitrova, Noori Sotudeh, Birgit Knoechel, Jens G. Lohr, Anna Montanaro, Sayalee V. Potdar, Julia Frede, Alexandria Van Scoyk, Shruti Bhatt, Praveen Anand, Jon C. Aster, David M Weinstock, Anthony G. Letai
Journal: Blood (2022)
Integrative Analysis of Genetic and Tumor Microenvironment Topology to Delineate Prognostic Subtypes in Mantle Cell Lymphoma
Authors: Sunandini Sharma, Alyssa C. Bouska, Alicia Gamboa, Roshia Ali, Issa Ismail Issa, Waseem G. Lone, Dylan T. Jochum, Weiwei Zhang, Salma Elhag, Dario Ghersi, Dalia ElGamal, Julie M. Vose, Chengfeng Bi, Akil Merchant, Javeed Iqbal
Journal: Blood (2022)
Multi-Omics Reveal Plasma Molecular Signatures of B-ALL Patients during CAR-T Cell Therapy
Authors: Jianghua Wu, Lu Tang, Mengyi Du, Chenggong Li, Haiming Kou, Huiwen Jiang, Wenjing Luo, Yinqiang Zhang, Zhongpei Huang, Danying Liao, Wei Xiong, Heng Mei, Yu Hu
Journal: Blood (2022)
Quality of Life and Personal Life Goals of Adult Sickle Cell Disease Patients after Curative Allogeneic Stem Cell Transplantation: A Mixed Methods Study
Authors: Elisabeth Dovern, Sterre J.A.M. Nijland, Maud M. Van Muilekom, Liesbeth E.M. Suijk, Hilda Mekelenkamp, Bart J. Biemond, Lotte Haverman, Erfan Nur
Journal: Blood (2022)
Consolidation with Allogeneic Hematopoietic Cell Transplant Improved Survival Outcomes of Adults with Relapsed / Refractory Acute Lymphoblastic Leukemia Following Response to Memory-Enriched CD19CAR T Cells
Authors: Ibrahim Aldoss, Samer Khaled, Xiuli Wang, Joycelynne Palmer, Yan Wang, Jamie R. Wagner, Mary C. Clark, Jennifer Simpson, Jinny Paul, Vibhuti Vyas, Sheng-Hsuan Chien, Anthony S. Stein, Vinod A. Pullarkat, Amandeep Salhotra, Monzr M. Al Malki, Sandra Thomas, L. Elizabeth Budde, Guido Marcucci, Christine E. Brown, Stephen J. Forman
Journal: Blood (2022)
Is It Possible to Omit Bone Marrow Biopsy in Diagnostic Workup in Patients with Newly Diagnosed Primary CNS Lymphoma? a Retrospective Analysis in the PET/CT Era
Authors: Jelena Jelicic, Dennis Lund Hansen, Sarah Sand Carlsen, Michael Thorsgaard, Ditte Hersby, Karina Kannik, Amalie Emilie Munksgaard, Thomas S. Larsen, Karen Juul-Jensen
Journal: Blood (2022)
Rker-050, a Novel Activin Receptor Type II Ligand Trap, Rescued Anemia and Reduced Bone Loss in a Mouse Model of Myelodysplastic Syndromes
Authors: Blake S Moses, Chris Materna, Remya Nathan, Tandicka Nurse, Keith Babbs, Claire Tseng, Ffolliott Fisher, Jasbir Seehra, Jenn Lachey
Journal: Blood (2022)
Derivation and External Validation of Clinical Risk Assessment Model for Cancer Associated Thrombosis in Two Unique U.S. Healthcare Systems
Authors: Ang Li, Jennifer La, Sarah B May, Danielle Guffey, Wilson L Da Costa, Christopher I Amos, Emily Milner, Raka Bandyo, Carolina Granada, Nimrah Riaz, Nhan V Do, Mary Brophy, Vipul Chitalia, J. Michael Gaziano, David A. Garcia, Marc Carrier, Christopher R. Flowers, Neil Zakai, Nathanael Fillmore
Journal: Blood (2022)
Real Life Analysis of Brentuximab Vedotin (BV) Use As Consolidation Therapy in Patients with Hodgkin's Lymphoma (HL) with High Risk of Relapse after Autologous Stem Cell Transplantation (ASCT). a Retrospective Analysis of the EBMT Lymphoma Working Party
Authors: Maria Carmen Martinez Munoz, Mariana Bastos-Oreiro, Ariane Boumendil, Hervé Finel, Ali Bazarbachi, Mohsen Alzahrani, Arpad Illes, Didier Blaise, Ioanna Sakellar, Carlos Solano, Alessandro Pulsoni, Tsila Zuckerman, Nadira Durakovic, Luca Castagna, Simona Sica, Stéphanie Guidez, Jean-Henri Bourhis, Ramón García-Sanz, Muhlis Cemm Ar, Aspasia Stamatoulas Bastard, Javier Briones, Saad Aktar, Ron Ram, Inmaculada Heras, Marie Thérèse Rubio, Mario Petrini, Mario Ojeda-Uribe, Bertram Glass, Anna Sureda
Journal: Blood (2022)
Real-Life Comparative Analysis of Prognostic Risk Classification According to ELN 2010, 2017 and 2022 in AML Patients
Authors: Clara Aparicio Pérez, Ana Camila Gonzalez Teomiro, Maria Carmen Martinez Losada, Manuel Yébenes Ramírez, Carmen Martin Calvo, Esther Prados de La Torre, Joaquín Sánchez-Garcia, Josefina Serrano
Journal: Blood (2022)
MO-TRANS: A Phase 2b Placebo-Controlled Study of Mocravimod As Adjunctive and Maintenance Treatment in AML Patients Undergoing Allogeneic Hematopoietic Cell Transplant
Authors: Marcos de Lima, Florent Malard, Eduardo Olavarria, Estefanía Pérez López, Michael Medinger, Elisabeth Kueenburg, Malika Souquieres, Julien Cachat, Christos Stylianou, Patrice Chevallier
Journal: Blood (2022)
<i>RUNX1</i> Mutations Have Distinct Prognostic and Clinical Implication in Pediatric AML: Results of the AML-BFM Study Group
Authors: Stephanie Sendker, Markus Schneider, Amani Awada, Eser Orhan, Michael Sendker, Lina Hoffmeister, Evangelia Antoniou, Dirk Reinhardt, Nils Von Neuhoff
Journal: Blood (2022)